# A Study Comparing User Experience of Different Delivery Devices for Glucagon

> **NCT03765502** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 99 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** Nasal Glucagon Device (NG)
- **DEVICE:** GEK
- **DRUG:** IM Glucagon

## Key facts

- **NCT ID:** NCT03765502
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-19
- **Primary completion:** 2019-01-03
- **Final completion:** 2019-01-03
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03765502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03765502, "A Study Comparing User Experience of Different Delivery Devices for Glucagon". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03765502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*